好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Effect of early use of AbobotulinumtoxinA (Dysport®) after stroke on spasticity progression: first results of a pilot study
Neuro-rehabilitation
P4 - (-)
032
Authors/Disclosures
Raymond Rosales (The Cathay Drug Co., Inc.)
PRESENTER
Dr. Rosales has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Jovita Balcaitiene No disclosure on file
Pascal Maisonobe Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma. Pascal Maisonobe has received personal compensation for serving as an employee of Ipsen.
No disclosure on file